Genetic Variants of Steroidogenesis and Gonadotropin Pathways and Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-analysis

dc.contributor.authorSharma, Priya
dc.contributor.authorSingh, Abhilash Kumar
dc.contributor.authorSenapati, Sabyasachi
dc.contributor.authorKapoor, Harmanpreet Singh
dc.contributor.authorGoyal, Lajya Devi
dc.contributor.authorKaur, Balpreet
dc.contributor.authorKamra, Pooja
dc.contributor.authorKhetarpal, Preeti
dc.date.accessioned2024-01-21T10:54:19Z
dc.date.accessioned2024-08-14T07:41:03Z
dc.date.available2024-01-21T10:54:19Z
dc.date.available2024-08-14T07:41:03Z
dc.date.issued2023-10-25T00:00:00
dc.description.abstractGenetic variants are predisposing factors to polycystic ovary syndrome (PCOS), a multifactorial condition that often gets triggered due to various environmental factors. The study investigates the association of the variants of genes that are involved in the steroidogenesis pathway or gonadotropin pathway with the risk of PCOS. Appropriate keywords for predetermined genes were used to search in PubMed, Google Scholar, Science Direct, and Central Cochrane Library up to January 11, 2023. PROSPERO (CRD42022275425). Inclusion criteria: (a) case�control study; (b) genotype or allelic data. Exclusion criteria were: (a) duplicate studies; (b) clinical trials, systematic reviews, meta-analysis or conference abstract, case reports; (c) other than the English language; (d) having insufficient data; e) genetic variants for which meta-analysis has been reported recently and does not have a scope of the update. Various genetic models were applied as per data availability. Overall 12 variants of 7 genes were selected for the analysis. Relevant data were extracted from 47 studies which include 10,584 PCOS subjects and 16,150 healthy controls. Meta-analysis indicates a significant association between TOX3 rs4784165 [ORs = 1.08, 95% CI (1.00�1.16)], HMGA2 rs2272046 [ORs = 2.73, 95% CI (1.97�3.78)], YAP1 rs1894116 [OR = 1.22, 95% CI (1.13�1.33)] and increased risk of PCOS. Whereas FSHR rs2268361 [ORs = 0.84, 95% CI (0.78�0.89)] is associated with decreased PCOS risk. When sensitivity analysis was carried out, the association became significant for CYP19 rs700519 and FSHR rs6165 under an additive model. In addition, C9Orf3 rs3802457 became significantly associated with decreased PCOS risk with the removal of one study. Insignificant association was observed for CYP19A (rs2470152), FSHR (rs2349415, rs6166), C9Orf3 (rs4385527), GnRH1 (rs6185) and risk of PCOS. Our findings suggest association of CYP19A (rs700519), TOX3 (rs4784165), HMGA2 (rs2272046), FSHR (rs6165, rs2268361), C9orf3 (rs3802457), and YAP1 (rs1894116) with risk for PCOS. � Mary Ann Liebert, Inc.en_US
dc.identifier.doi10.1089/met.2023.0127
dc.identifier.issn15404196
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/4278
dc.identifier.urlhttps://www.liebertpub.com/doi/10.1089/met.2023.0127
dc.language.isoen_USen_US
dc.publisherMary Ann Liebert Inc.en_US
dc.subjectgenetic varianten_US
dc.subjectgonadotropinen_US
dc.subjectmeta-analysisen_US
dc.subjectpathwayen_US
dc.subjectPCOSen_US
dc.subjectsteroidogenesisen_US
dc.titleGenetic Variants of Steroidogenesis and Gonadotropin Pathways and Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-analysisen_US
dc.title.journalMetabolic Syndrome and Related Disordersen_US
dc.typeArticleen_US
dc.type.accesstypeClosed Accessen_US

Files